Abiopharma

🔍 Shellberg Jeffrey D. (Executive)

Company: Bridgewater Bancshares Inc (BWB)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Sold 62 shares of Common Stock at $18.5 per share (Direct)
  Date: 2026-05-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 62,426.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 355,000.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 87,000.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | shares_owned_after: 266,187.00

Footnotes:

• F1: Shares of common stock are held by Mr. Shellberg as trustee of the Susan K. Shellberg Marital Trust dated July 16, 2024. Mr. Shellberg possesses voting and investment power with respect to the shares of common stock held by the Susan K. Shellberg Marital Trust dated July 16, 2024.
• F2: Shares of common stock are held by Mr. Shellberg as trustee of the Jeffrey D. Shellberg Trust under agreement dated October 1, 2014. Mr. Shellberg possesses voting and investment power with respect to the shares of common stock held by the Jeffrey D. Shellberg Trust under agreement dated October 1, 2014.
• F3: Shares of common stock are held by Mr. Shellberg as trustee of the Susan K Shellberg Family Trust dated July 16, 2024. Mr. Shellberg possesses voting and investment power with respect to the shares of common stock held by the Susan K. Shellberg Family Trust dated July 16, 2024.